Sex differences in TLR2 and TLR4 expression and their effect on coxsackievirus-induced autoimmune myocarditis

Brian J Roberts1, Mohamad Moussawi, Sally A Huber

  • 1Department of Pathology, Center for Immunology and Infectious Disease, University of Vermont, Burlington, VT 05446, United States. brian.roberts@uvm.edu

Insights

Toll-like receptor 2 (TLR2) signaling exacerbates coxsackievirus myocarditis in male mice by suppressing regulatory T-cells and promoting a Th1 response. This TLR2 activity contributes to the observed sex bias in viral heart inflammation.

Area of Science:

  • Immunology
  • Virology
  • Cardiovascular Research

Background:

  • Coxsackievirus B3 (CVB3) causes myocarditis with a sex bias, males exhibit more severe cardiac inflammation.
  • Males develop a Th1 immune response, while females develop a Th2 response.
  • Toll-like receptors (TLRs) are crucial in pathogen immune response development.

Purpose of the Study:

  • To investigate the role of TLRs, specifically TLR2, in coxsackievirus-induced myocarditis.
  • To assess the impact of TLR signaling on T-cell responses and myocarditis severity in a sex-dependent manner.

Main Methods:

  • Infection of wild-type and Toll-like receptor 2 knockout (TLR2-/-) male and female mice with CVB3.
  • Assessment of viral replication, myocarditis, helper T-cell (Th1/Th2) generation, and regulatory T-cell (Treg) generation.
  • Treatment of wild-type mice with TLR2 and TLR4 agonists (Pam3CSK4 and LPS) to evaluate immune modulation.

Main Results:

  • TLR2-/- mice exhibited reduced Th1 immune responses compared to controls.
  • TLR agonist treatment increased Th1 responses in both male and female mice.
  • TLR signaling decreased FoxP3+ regulatory T-cells in male mice but not females, correlating with increased myocarditis.

Conclusions:

  • TLR2 signaling plays a significant role in the sex bias of CVB3-induced myocarditis.
  • Suppression of regulatory T-cells by TLRs in males contributes to their heightened susceptibility to severe cardiac inflammation.
  • Targeting TLRs may offer therapeutic strategies for managing viral myocarditis, considering sex-specific immune responses.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...